Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Luteolin and Rheumatoid Arthritis: Scientific Evidence Overview

Luteolin is a natural flavonoid found in various fruits, vegetables, and herbs. Its potential use in supporting or treating Rheumatoid Arthritis (RA) is based primarily on preclinical scientific research rather than traditional medicine. Several in vitro (cell culture) and animal studies have indicated that luteolin possesses anti-inflammatory and immunomodulatory properties, which may be beneficial in the context of autoimmune diseases like RA.

Specifically, luteolin has been shown to inhibit the production of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6, which play key roles in the pathogenesis of RA. It also suppresses the activation of NF-κB and MAPK signaling pathways, both of which contribute to inflammation and joint destruction in RA. Some studies in animal models of arthritis have demonstrated that luteolin administration can reduce joint swelling, decrease inflammatory markers, and limit cartilage and bone damage.

However, there is a lack of robust clinical evidence in humans. No large-scale randomized controlled trials have been conducted to directly assess the efficacy and safety of luteolin in RA patients. Thus, while preclinical results are promising and provide a rationale for further investigation, luteolin cannot currently be recommended as a standalone or primary therapy for RA based on existing human data.

In summary, luteolin's use for RA is supported by some scientific evidence from laboratory and animal studies, but clinical validation in humans is still lacking.

More about luteolin
More about Rheumatoid Arthritis

Other ingredients used for Rheumatoid Arthritis

Other health conditions supported by luteolin

Products containing luteolin

Pure Encapsulations Brain Reset
Pure Encapsulations Hist Reset
Pure Encapsulations LVR Formula
Pure Encapsulations LVR Formula
Pure Encapsulations Ultra B-Complex with PQQ